Trial Profile
Real world experience of Natalizumab in patient with Crohn disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2017
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 29 Nov 2017 New trial record